Google’s Insulin Resistance Tracking is a Bold Claim Without the Proof

Google recently unveiled the Pixel Watch 5 at its Made by Google event, positioning the device as a proactive health companion. Among a suite of updates—including a faster Qualcomm Snapdragon W5 Gen 2 platform and a more integrated Gemini AI—the most provocative addition is the ability to track insulin resistance.

According to reporting from TechCrunch, Google claims this feature identifies metabolic health changes associated with insulin resistance and an increased risk of developing type 2 diabetes or prediabetes. The process is not based on a direct medical measurement; instead, it combines signals from physical activity, heart rate, sleep, and other health data, which a large sensor model then analyzes to spot long-term trends. Users will receive a summary of these trends once a month.

Here is the problem: while Google is quick to provide the numbers for its other features, the evidence for insulin resistance tracking is conspicuously absent. For its blood pressure pattern tracking, TechCrunch reports that Google claims the feature was tested against 24-hour blood pressure monitors using a waveform model trained on over 500,000 people and 1 billion minutes of data.

No such validation is provided for the insulin resistance feature.

In my view, this is the definition of wellness vaporware. Google is asking consumers to pay a premium—the Pixel Watch 5 starts at $399 for the 41mm model and $429 for the 45mm model, representing a $50 price hike over the previous generation, as noted by The Verge—for a metabolic insight that lacks transparent, peer-reviewed backing.

To be clear, The Verge explicitly notes that neither the blood pressure nor the insulin resistance features are diagnostic. However, there is a vast chasm between a "non-diagnostic trend" and a feature that claims to identify risks for a chronic disease like type 2 diabetes. When a company markets a device's ability to track a complex metabolic state, the burden of proof should be scientific, not just algorithmic.

Google is betting that users will be enamored by the "proactive" nature of the Health Guardian suite. They are bundling this metabolic tracking with other high-stakes features, such as a Breathing Emergency Detection tool that contacts emergency services when it detects a persistent drop in oxygen saturation (specifically around 83 percent, according to The Verge).

While the emergency detection tool has a clear, binary trigger, insulin resistance is a nuanced physiological state. Without disclosed clinical trials or peer-reviewed data to prove that combining heart rate and sleep patterns actually correlates accurately with insulin resistance, this feature is little more than a sophisticated guess.

Until Google provides the same level of data transparency for its metabolic tracking as it did for its blood pressure waveforms, the Pixel Watch 5's most touted health leap remains an expensive gimmick. For the health-conscious consumer, a monthly summary of "trends" is not a substitute for medical evidence.